About Satori Pharmaceuticals
Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of innovative disease-modifying therapies for Alzheimer’s disease.
Satori is built on a strong foundation of innovative technology with a team of experienced pharmaceutical R&D drug discoverers and funding from leading venture capital firms.
Satori was established in 2005 by PureTech Ventures, Dr. Mark Findeis, and a group of renowned Alzheimer’s and neurodegenerative disease experts.
